The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Ceziboe 0.25 mg solution for injection in pre-filled syringe



Sun Pharmaceutical Industries Europe B.V.PA2050/005/001

Main Information

Trade NameCeziboe 0.25 mg solution for injection in pre-filled syringe
Active SubstancesCetrorelix
Dosage FormSolution for injection in pre-filled syringe
Licence HolderSun Pharmaceutical Industries Europe B.V.
Licence NumberPA2050/005/001

Group Information

ATC CodeH01CC02 cetrorelix

Status

License statusAuthorised
Licence Issued12/02/2021
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back